欧洲肥胖治疗市场规模、趋势、增长报告2032

Europe Obesity Treatment Market

市场规模（十亿美元）

CAGR : 14.00 %

USD 7.48 Million USD 21.38 Million 2024 2032

Forecast Period	2025 –2032
Market Size (Base Year)	USD 7.48 Million
Market Size (Forecast Year)	USD 21.38 Million
CAGR	14.00 %
Major Markets Players	Dummy1 Dummy2 Dummy3 Dummy4 Dummy5 Request For Unlock

歐洲肥胖治療市場細分，依治療類型（藥物治療（抗肥胖藥物）、減重手術、行為與生活型態療法、非侵入性/內視鏡手術、醫療器材與科技）、年齡層（成人肥胖治療、老年肥胖治療、兒童肥胖治療）、分銷通路（網路藥局、零售藥局、體重管理診所、醫院藥局、健康與健身中心）、分工（線上藥局、零售藥局、體重管理診所、醫院藥局、健康與健身中心）、 II 類型（I 203）

歐洲肥胖治療市場規模

2024 年歐洲肥胖治療市場價值為748 萬美元，預計到 2032 年將達到 2,138 萬美元
在 2025 年至 2032 年的預測期內，市場可能會以14.0% 的複合年增長率成長，主要原因是肥胖症的盛行率不斷上升
這一增長得益於抗肥胖藥物的創新、減重和代謝手術的成長等因素。此外，數位健康解決方案在肥胖治療中的整合也帶來了新的成長。

歐洲肥胖治療市場分析

肥胖是一種慢性疾病，其特徵是脂肪過度堆積，會增加心血管疾病、2 型糖尿病、高血壓和某些癌症等嚴重健康併發症的風險
治療方案包括生活方式改變、藥物治療、醫療器材以及減肥手術，旨在實現可持續的減肥效果並改善整體健康狀況
歐洲肥胖治療市場的發展受到久坐不動的生活方式、不健康的飲食習慣和遺傳因素導致的肥胖盛行率上升的推動。 GLP-1受體激動劑和食慾抑制劑等藥物幹預措施在體重管理中發揮至關重要的作用，此外，行為療法和生活方式的改變也發揮著重要作用。胃繞道手術和袖狀胃切除術等減重手術也越來越受到關注，成為治療嚴重肥胖的有效長期解決方案。
對微創手術和創新減肥藥物的需求不斷增長，進一步推動了市場成長
北美仍然是歐洲肥胖治療市場的主導地區，得益於完善的醫療基礎設施、高肥胖率以及對體重管理解決方案的持續研究

例如，美國在 GLP-1 受體激動劑（如索馬魯肽和利拉魯肽）的應用方面處於領先地位，並且在減肥的非侵入性醫療設備方面也取得了進展

隨著對肥胖管理和預防性醫療保健的日益重視，歐洲市場正在對新療法、醫療技術和以患者為中心的解決方案進行大量投資，推動整個行業的擴張

報告範圍和肥胖治療市場細分

屬性	歐洲肥胖治療市場關鍵市場洞察
涵蓋的領域	依治療類型分類- 藥物治療（抗肥胖藥物）、減重手術、行為與生活型態療法、非侵入性/內視鏡手術及醫療器材與技術依年齡層- 成人肥胖治療、老年肥胖治療及兒童肥胖治療按分銷管道- 網路藥局、零售藥局、體重管理診所、醫院藥局和健康與健身中心。依患者類型- III 類、II 類和 I 類
覆蓋國家	歐洲德國英國法國俄羅斯義大利西班牙火雞波蘭荷蘭瑞士挪威奧地利愛爾蘭歐洲其他地區
主要市場參與者	諾和諾德公司（丹麥）禮來公司（美國）美敦力（美國）波士頓科學公司（美國）強生服務公司（美國） Altimmune（美國）阿斯特捷利康（英國） Allurion（美國）安進公司（美國） Arena Pharmaceuticals Ltd（美國） Currax pharmaceuticals LLC（美國） COUSIN SURGERY（法國） F. Hoffmann-La Roche Ltd（瑞士） Fitterfly Healthtech Pvt. Ltd.（印度） Morphic Medical, Inc（美國） Noom, Inc.（美國） Omada Health Inc（美國） Reshape Lifesciences Inc.（美國）拉齊爾（以色列） Spatz FGIA Inc.（美國）賽諾菲（法國）薩尼奧納（丹麥） USGI醫療（美國） VIVUS LLC.（美國） Viking Therapeutics（美國）
市場機會	生活方式相關疾病的盛行率不斷上升可支配所得的增加增強了肥胖治療相關產品的購買力
加值資料資訊集	除了對市場價值、成長率、細分、地理覆蓋範圍和主要參與者等市場情景的洞察之外，Data Bridge Market Research 策劃的市場報告還包括進出口分析、生產能力概覽、生產消費分析、價格趨勢分析、氣候變遷情景、供應鏈分析、價值鏈分析、原材料/消耗品概覽、供應商選擇標準、PESTLE 分析、波特分析和監管框架。

歐洲肥胖治療市場趨勢

數位化和人工智慧驅動的體重管理解決方案的採用率不斷上升

歐洲肥胖治療市場的一個主要趨勢是越來越多地採用數位化和人工智慧驅動的體重管理解決方案
這些創新技術透過提供個人化治療計劃、即時監控和數據驅動的洞察來優化減肥策略，從而增強肥胖管理
- 例如，人工智慧行動應用程式和穿戴式裝置可以追蹤身體活動、卡路里攝取量和代謝率，提供客製化建議以提高依從性和效果
遠距醫療平台和虛擬指導透過提供遠距諮詢、行為諮詢和藥物管理為患者提供進一步的支持，從而實現更有效、更永續的減肥
這一趨勢正在透過提高患者參與度、增強長期治療成功率以及推動肥胖治療市場對數位健康解決方案的需求，徹底改變肥胖護理。

歐洲肥胖治療市場動態

司機

肥胖盛行率不斷上升

由於久坐的生活方式、不良的飲食習慣和遺傳傾向，肥胖流行病正在加劇，導致與肥胖相關的健康併發症（如糖尿病、心血管疾病和高血壓）急劇增加
城市化和技術進步導致體力活動減少，而加工食品和高熱量食品的廣泛消費進一步加劇了體重增加
遺傳因素也起著重要作用，許多人容易患上導致肥胖的代謝紊亂。隨著肥胖率持續飆升，對有效治療方案的需求正在顯著增長，包括藥物治療、減肥手術和醫學監督下的體重管理計劃。

例如

根據世界衛生組織 (WHO) 提供的數據，2024 年 3 月，歐洲肥胖疫情正在加劇，2022 年每 8 人中就有 1 人患有肥胖症。自 1990 年以來，成人肥胖率翻了一番，青少年肥胖率翻了兩番。超過 25 億成年人超重，其中 8.9 億人患有肥胖症。肥胖率上升導致糖尿病、心臟病和癌症的風險增加，從而刺激了對有效治療方法的需求，並推動了市場成長。
美國疾病管制與預防中心 (CDC) 指出，截至 2024 年 9 月，2021 年 8 月至 2023 年 8 月期間，40.3% 的成年人患有肥胖症，其中男性肥胖率為 39.2%，女性肥胖率為 41.3%。 40-59 歲年齡層的成年人患病率最高（46.4%），其次是 20-39 歲年齡層（35.5%）和 60 歲以上年齡層（38.9%）。預計日益加重的肥胖負擔將推動對有效肥胖治療的需求。
根據《世界肥胖地圖集》2024年的數據，到2035年，79%的超重和肥胖成年人以及88%的超重和肥胖兒童將居住在中低收入國家（LMIC）。預計肥胖成年人的數量將從2020年的8.1億增加到2035年的15.3億。肥胖盛行率的上升正在增加對肥胖治療解決方案的需求，從而推動市場成長。
日益加重的患者負擔促使醫療保健提供者、製藥公司和健康計畫擴大其服務範圍，使肥胖盛行率的上升成為歐洲肥胖治療市場的主要驅動力

機會

生活方式相關疾病的盛行率不斷上升

隨著越來越多的人尋求控制體重並減輕相關的健康風險，製藥公司和醫療保健提供者受到激勵去創新和擴大其產品範圍
這一趨勢促進了針對不同患者需求的新藥物、手術方案和綜合生活方式計劃的開發

例如

2023 年 5 月，NCBI 表示，預計到 2030 年，全球將有超過 10 億人患有肥胖症。肥胖相關死亡率和合併症（如糖尿病、心血管疾病、慢性腎臟病和幾種癌症）的發生率同樣高得驚人，平均每年造成 500 萬人死亡，傷殘調整生命年為 1.6 億年
2023年6月，根據《中國藥學報B》發表的一篇文章，肥胖是導致癌症、心血管疾病、第2型糖尿病、肝病和其他疾病的重要因素
2021年4月，美國心臟協會期刊發表的一篇文章指出，肥胖直接導致心血管危險因子的發生，包括血脂異常、第2型糖尿病、高血壓和睡眠障礙。肥胖也會導致心血管疾病的發生和心血管疾病死亡，且獨立於其他心血管危險因子。
2023 年 4 月，MoneyControl 的一項研究表明，印度的生活方式疾病數量激增，包括肥胖和膽固醇異常等早期風險因素的盛行率上升

此外，人們對肥胖健康後果的認知不斷提高，促使消費者積極主動地進行健康管理。在各國政府和衛生組織大力倡導健康生活方式的推動下，肥胖治療市場可望大幅成長。
這一勢頭吸引了投資並推動了研發工作，為廣泛的治療幹預措施鋪平了道路，以滿足不斷增長的患者群體的需求

克制/挑戰

與肥胖治療相關的長期隨訪

與肥胖治療相關的長期追蹤主要是由於此類計劃的複雜性和資源密集性，通常需要持續的監測和支持，以確保持續的體重減輕和管理，其中可以包括定期諮詢、營養指導和行為療法
這些長期承諾給醫療保健系統帶來了負擔，並給患者和醫療服務提供者帶來了後勤挑戰，導致護理方面的潛在差距和治療依從性的不一致

例如

2022年12月，根據AJMC的說法，管理肥胖需要病人和知情的臨床醫生持續的合作。管理肥胖需要患者和知情的臨床醫生持續的合作。
2022年9月，《美國醫學會雜誌》(JAMA Network) 報道，一項針對175名患者的研究顯示，3個月後，94名（53.7%）患者的體重減輕至少5%，26名（14.9%）患者的體重減輕至少10%。在102名接受6個月追蹤的患者中，89名（87.3%）患者的體重減輕至少5%，56名（54.9%）患者的體重減輕至少10%，24名（23.5%）患者的體重減輕至少15%，8名（7.8%）患者的體重減輕至少20%。
2021年11月，美國國家醫學圖書館發表的一篇文章指出，確保長期追蹤對減重患者至關重要。低品質的追蹤被認為是減重手術療效不佳的風險因素，但追蹤的多樣性和有效性也是臨床研究的決定因素。

此外，長期追蹤的必要性也阻礙了患者尋求治療。許多潛在患者可能擔心定期復診和監測所帶來的持續投入和費用，認為這些措施令人望而生畏或不便。
這種猶豫阻礙了市場成長，因為潛在消費者會迴避需要持續參與和問責的項目
因此，促進有效的長期追蹤的挑戰可能會限制肥胖治療的整體有效性及其在目標族群中的接受度

歐洲肥胖治療市場範圍

市場根據類型、產品類型、吸收部位、年齡層、來源、交付方式、性別和分銷管道進行細分。

分割	細分
治療類型	藥物治療（抗肥胖藥物） GLP-1受體激動劑 GIP/GLP-1受體雙激動劑中樞作用厭食藥芬特明芬特明-托吡酯納曲酮-安非他酮脂肪酶抑制劑脫氧膽酸其他的減重手術按類型限制性手術袖狀胃切除術可調式胃束帶手術聯合手術 Roux-en-Y胃繞道手術（RYGB）微創胃繞道手術（MGB）吸收不良手術依方法腹腔鏡手術機器人輔助手術開放性手術行為與生活方式療法飲食幹預行為矯正療法體力活動計劃心理諮商非侵入性/內視鏡手術內視鏡袖狀胃成形術（ESG）胃內水球（IGB） Orbera胃內球囊 Spatz 可調氣球系統抽吸療法（AspireAssist）經口胃成形術（TOGA）醫療設備與技術人工智慧和數位體重管理平台胃電刺激裝置（Maestro 系統）
年齡組	成人肥胖症治療老年肥胖症治療兒童肥胖症治療
分銷通路-	網路藥局零售藥局體重管理診所醫院藥房健康與健身中心
患者類型	III 類 II 類 I類

歐洲肥胖治療市場區域分析

德國是第一型和第2型糖尿病胰島素市場的主導地區

德國引領歐洲肥胖治療市場，其主要原因是肥胖盛行率高、醫療保健基礎設施先進以及創新體重管理解決方案的廣泛採用
由於對 GLP-1 受體激動劑、減肥手術和數位體重管理平台等藥物治療的需求不斷增長，德國佔據了相當大的市場份額
此外，人們對肥胖相關健康風險的認識不斷提高，以及人工智慧減肥計劃、遠距醫療諮詢和非侵入性治療解決方案的日益普及，繼續推動該地區的市場擴張

波蘭預計將實現最高成長率

受肥胖盛行率上升、醫療保健投資增加以及對體重管理解決方案認識不斷提高的推動，波蘭地區預計將成為歐洲肥胖治療市場中成長率最高的地區。
由於生活方式的轉變、城市化進程的加快以及肥胖相關健康併發症的增多，波蘭、俄羅斯和羅馬尼亞等國家正在成為主要市場。
波蘭的醫療基礎設施不斷完善，醫療減重治療的需求也日益增長，因此仍然是肥胖管理的關鍵市場。該國正在見證藥物治療、減肥手術和數位化體重管理計畫的普及率不斷上升。

歐洲肥胖治療市場份額

市場競爭格局按競爭對手提供詳細資料。詳細資訊包括公司概況、公司財務狀況、收入、市場潛力、研發投入、新市場計劃、歐洲業務、生產基地和設施、生產能力、公司優勢和劣勢、產品發布、產品寬度和廣度以及應用主導地位。以上提供的數據點僅與公司在市場中的重點相關。

市場中主要的市場領導者有：

諾和諾德公司（丹麥）
禮來公司（美國）
美敦力（美國）
波士頓科學公司（美國）
強生服務公司（美國）
Altimmune（美國）
阿斯特捷利康（英國）
Allurion（美國）
安進公司（美國）
Arena Pharmaceuticals Ltd（美國）
Currax pharmaceuticals LLC（美國）
COUSIN SURGERY（法國）
F. Hoffmann-La Roche Ltd（瑞士）
Fitterfly Healthtech Pvt. Ltd.（印度）
Morphic Medical, Inc（美國）
Noom, Inc.（美國）
Omada Health Inc（美國）
Reshape Lifesciences Inc.（美國）
拉齊爾（以色列）
Spatz FGIA Inc.（美國）
賽諾菲（法國）
薩尼奧納（丹麥）
USGI醫療（美國）
VIVUS LLC.（美國）
Viking Therapeutics（美國）

歐洲肥胖治療市場的最新發展

2024年10月，VIVUS和UpScriptHealth推出了ChooseQ. online，這是一個遠距醫療平台，方便患者便捷地使用QSYMIA進行體重管理。該服務允許患者在線諮詢醫療保健提供者，並直接在家中接受QSYMIA。該計劃旨在透過遠距醫療提高肥胖治療的可近性。
2024年10月，Zealand Pharma宣布勃林格殷格翰的Survodutide (BI 456906)獲得美國FDA突破性療法認定，用於治療伴有中度或晚期纖維化的非肝硬化代謝功能障礙相關脂肪性肝炎(MASH)。此認定因其II期臨床試驗結果良好，將加速其研發進程。
2025年3月，Zealand Pharma宣布，長效胰淀素類似物Petrelintide的2b期ZUPREME-1試驗已完成受試者招募。 Petrelintide旨在治療超重和肥胖。該試驗將在42週內評估不同劑量Petrelintide對體重、安全性和耐受性的影響，預計結果將於2025年公佈。
2025年3月，專注於醫療美容市場新一代處方藥的製藥公司Raziel Therapeutics宣佈在中國啟動RZL-012的第三期臨床研究，旨在減少頦下脂肪（SMF）。減少SMF是RZL-012的首個適應症，在塑身美容減脂治療中具有潛在應用。
2022年10月，減重和代謝健康解決方案領域的領導者ReShape Lifesciences宣布，美國代謝和減肥手術學會(ASMBS)和國際肥胖和代謝紊亂外科聯合會(IFSO)發布了最新的代謝和減肥手術指南，其中現已涵蓋Lap-Band腹帶手術。這些指南將取代美國國立衛生研究院(NIH)於1991年制定的已有30年歷史的標準。

SKU-73839

Get online access to the report on the World's First Market Intelligence Cloud

Click on image to enlarge

Interactive Data Analysis Dashboard
Company Analysis Dashboard for high growth potential opportunities
Research Analyst Access for customization & queries
Competitor Analysis with Interactive dashboard
Latest News, Updates & Trend analysis
Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking

Request for Demo

表格列表

TABLE 1 OBESITY PREVALENCE BY REGION (ADULTS)

TABLE 2 OBESITY PREVALENCE BY GENDER (ADULTS)

TABLE 3 OBESITY PREVALENCE BY AGE (ADULTS)

TABLE 4 EUROPE CLINICAL TRIAL MARKET FOR OBESITY TREATMENT

TABLE 5 DISTRIBUTION OF PRODUCTS AND PROJECTS BY PHASE EUROPE OBESITY TREATMENT MARKET

TABLE 6 DISTRIBUTION OF PROJECTS BY THERAPEUTIC AREA AND PHASE EUROPE OBESITY TREATMENT MARKET

TABLE 7 EUROPE OBESITY STATISTICS (2022)

TABLE 8 EUROPE OBESITY TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 9 EUROPE PHARMACOLOGICAL TREATMENTS (ANTI-OBESITY DRUGS) IN OBESITY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 10 EUROPE PHARMACOLOGICAL TREATMENT (ANTI-OBESITY DRUGS) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 11 EUROPE CENTRALLY ACTING ANORECTICS IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 12 EUROPE BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 13 EUROPE BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 14 EUROPE RESTRICTIVE SURGERIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 15 EUROPE COMBINATION SURGERIES IN OBESITY TREATMENT MARKET, BY CLASS, 2018-2032 (USD THOUSAND)

TABLE 16 EUROPE BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY APPROACH, 2018-2032 (USD THOUSAND)

TABLE 17 EUROPE BEHAVIORAL & LIFESTYLE THERAPY IN OBESITY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 18 EUROPE BEHAVIORAL & LIFESTYLE THERAPY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 19 EUROPE NON-INVASIVE/ ENDOSCOPIC PROCEDURES IN OBESITY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 20 EUROPE NON-INVASIVE/ ENDOSCOPIC PROCEDURES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 21 EUROPE INTRAGASTRIC BALLOON (IGB) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 22 EUROPE MEDICAL DEVICES & TECHNOLOGIES IN OBESITY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 23 EUROPE MEDICAL DEVICES & TECHNOLOGIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 24 EUROPE OBESITY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)

TABLE 25 EUROPE ADULT OBESITY TREATMENT IN OBESITY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 26 EUROPE GERIATRIC OBESITY TREATMENT IN OBESITY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 27 EUROPE PEDIATRIC OBESITY TREATMENT IN OBESITY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 28 EUROPE OBESITY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 29 EUROPE ONLINE PHARMACIES IN OBESITY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 30 EUROPE RETAIL PHARMACIES IN OBESITY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 31 EUROPE WEIGHT MANAGEMENT CLINICS IN OBESITY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 32 EUROPE HOSPITAL PHARMACIES IN OBESITY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 33 EUROPE WELLNESS & FITNESS CENTERS IN OBESITY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 34 EUROPE OBESITY TREATMENT MARKET, BY PATIENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 35 EUROPE CLASS III IN OBESITY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 36 EUROPE CLASS II IN OBESITY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 37 EUROPE CLASS I IN OBESITY TREATMENT MARKET, BY REGION, 2018-2032 (USD THOUSAND)

TABLE 38 EUROPE OBESITY TREATMENT MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)

TABLE 39 EUROPE OBESITY TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 40 EUROPE PHARMACOLOGICAL TREATMENT (ANTI-OBESITY DRUGS) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 41 EUROPE CENTRALLY ACTING ANORECTICS IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 42 EUROPE BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 43 EUROPE RESTRICTIVE SURGERIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 44 EUROPE COMBINATION SURGERIES IN OBESITY TREATMENT MARKET, BY CLASS, 2018-2032 (USD THOUSAND)

TABLE 45 EUROPE BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY APPROACH, 2018-2032 (USD THOUSAND)

TABLE 46 EUROPE BEHAVIORAL & LIFESTYLE THERAPY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 47 EUROPE NON-INVASIVE/ ENDOSCOPIC PROCEDURES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 48 EUROPE INTRAGASTRIC BALLOON (IGB) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 49 EUROPE MEDICAL DEVICES & TECHNOLOGIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 50 EUROPE OBESITY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)

TABLE 51 EUROPE OBESITY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 52 EUROPE OBESITY TREATMENT MARKET, BY PATIENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 53 UNITED KINGDOM OBESITY TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 54 UNITED KINGDOM PHARMACOLOGICAL TREATMENT (ANTI-OBESITY DRUGS) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 55 UNITED KINGDOM CENTRALLY ACTING ANORECTICS IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 56 UNITED KINGDOM BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 57 UNITED KINGDOM RESTRICTIVE SURGERIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 58 UNITED KINGDOM COMBINATION SURGERIES IN OBESITY TREATMENT MARKET, BY CLASS, 2018-2032 (USD THOUSAND)

TABLE 59 UNITED KINGDOM BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY APPROACH, 2018-2032 (USD THOUSAND)

TABLE 60 UNITED KINGDOM BEHAVIORAL & LIFESTYLE THERAPY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 61 UNITED KINGDOM NON-INVASIVE/ ENDOSCOPIC PROCEDURES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 62 UNITED KINGDOM INTRAGASTRIC BALLOON (IGB) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 63 UNITED KINGDOM MEDICAL DEVICES & TECHNOLOGIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 64 UNITED KINGDOM OBESITY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)

TABLE 65 UNITED KINGDOM OBESITY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 66 UNITED KINGDOM OBESITY TREATMENT MARKET, BY PATIENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 67 GERMANY OBESITY TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 68 GERMANY PHARMACOLOGICAL TREATMENT (ANTI-OBESITY DRUGS) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 69 GERMANY CENTRALLY ACTING ANORECTICS IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 70 GERMANY BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 71 GERMANY RESTRICTIVE SURGERIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 72 GERMANY COMBINATION SURGERIES IN OBESITY TREATMENT MARKET, BY CLASS, 2018-2032 (USD THOUSAND)

TABLE 73 GERMANY BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY APPROACH, 2018-2032 (USD THOUSAND)

TABLE 74 GERMANY BEHAVIORAL & LIFESTYLE THERAPY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 75 GERMANY NON-INVASIVE/ ENDOSCOPIC PROCEDURES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 76 GERMANY INTRAGASTRIC BALLOON (IGB) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 77 GERMANY MEDICAL DEVICES & TECHNOLOGIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 78 GERMANY OBESITY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)

TABLE 79 GERMANY OBESITY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 80 GERMANY OBESITY TREATMENT MARKET, BY PATIENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 81 FRANCE OBESITY TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 82 FRANCE PHARMACOLOGICAL TREATMENT (ANTI-OBESITY DRUGS) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 83 FRANCE CENTRALLY ACTING ANORECTICS IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 84 FRANCE BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 85 FRANCE RESTRICTIVE SURGERIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 86 FRANCE COMBINATION SURGERIES IN OBESITY TREATMENT MARKET, BY CLASS, 2018-2032 (USD THOUSAND)

TABLE 87 FRANCE BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY APPROACH, 2018-2032 (USD THOUSAND)

TABLE 88 FRANCE BEHAVIORAL & LIFESTYLE THERAPY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 89 FRANCE NON-INVASIVE/ ENDOSCOPIC PROCEDURES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 90 FRANCE INTRAGASTRIC BALLOON (IGB) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 91 FRANCE MEDICAL DEVICES & TECHNOLOGIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 92 FRANCE OBESITY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)

TABLE 93 FRANCE OBESITY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 94 FRANCE OBESITY TREATMENT MARKET, BY PATIENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 95 ITALY OBESITY TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 96 ITALY PHARMACOLOGICAL TREATMENT (ANTI-OBESITY DRUGS) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 97 ITALY CENTRALLY ACTING ANORECTICS IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 98 ITALY BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 99 ITALY RESTRICTIVE SURGERIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 100 ITALY COMBINATION SURGERIES IN OBESITY TREATMENT MARKET, BY CLASS, 2018-2032 (USD THOUSAND)

TABLE 101 ITALY BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY APPROACH, 2018-2032 (USD THOUSAND)

TABLE 102 ITALY BEHAVIORAL & LIFESTYLE THERAPY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 103 ITALY NON-INVASIVE/ ENDOSCOPIC PROCEDURES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 104 ITALY INTRAGASTRIC BALLOON (IGB) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 105 ITALY MEDICAL DEVICES & TECHNOLOGIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 106 ITALY OBESITY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)

TABLE 107 ITALY OBESITY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 108 ITALY OBESITY TREATMENT MARKET, BY PATIENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 109 SPAIN OBESITY TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 110 SPAIN PHARMACOLOGICAL TREATMENT (ANTI-OBESITY DRUGS) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 111 SPAIN CENTRALLY ACTING ANORECTICS IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 112 SPAIN BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 113 SPAIN RESTRICTIVE SURGERIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 114 SPAIN COMBINATION SURGERIES IN OBESITY TREATMENT MARKET, BY CLASS, 2018-2032 (USD THOUSAND)

TABLE 115 SPAIN BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY APPROACH, 2018-2032 (USD THOUSAND)

TABLE 116 SPAIN BEHAVIORAL & LIFESTYLE THERAPY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 117 SPAIN NON-INVASIVE/ ENDOSCOPIC PROCEDURES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 118 SPAIN INTRAGASTRIC BALLOON (IGB) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 119 SPAIN MEDICAL DEVICES & TECHNOLOGIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 120 SPAIN OBESITY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)

TABLE 121 SPAIN OBESITY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 122 SPAIN OBESITY TREATMENT MARKET, BY PATIENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 123 RUSSIA OBESITY TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 124 RUSSIA PHARMACOLOGICAL TREATMENT (ANTI-OBESITY DRUGS) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 125 RUSSIA CENTRALLY ACTING ANORECTICS IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 126 RUSSIA BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 127 RUSSIA RESTRICTIVE SURGERIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 128 RUSSIA COMBINATION SURGERIES IN OBESITY TREATMENT MARKET, BY CLASS, 2018-2032 (USD THOUSAND)

TABLE 129 RUSSIA BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY APPROACH, 2018-2032 (USD THOUSAND)

TABLE 130 RUSSIA BEHAVIORAL & LIFESTYLE THERAPY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 131 RUSSIA NON-INVASIVE/ ENDOSCOPIC PROCEDURES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 132 RUSSIA INTRAGASTRIC BALLOON (IGB) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 133 RUSSIA MEDICAL DEVICES & TECHNOLOGIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 134 RUSSIA OBESITY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)

TABLE 135 RUSSIA OBESITY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 136 RUSSIA OBESITY TREATMENT MARKET, BY PATIENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 137 TURKEY OBESITY TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 138 TURKEY PHARMACOLOGICAL TREATMENT (ANTI-OBESITY DRUGS) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 139 TURKEY CENTRALLY ACTING ANORECTICS IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 140 TURKEY BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 141 TURKEY RESTRICTIVE SURGERIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 142 TURKEY COMBINATION SURGERIES IN OBESITY TREATMENT MARKET, BY CLASS, 2018-2032 (USD THOUSAND)

TABLE 143 TURKEY BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY APPROACH, 2018-2032 (USD THOUSAND)

TABLE 144 TURKEY BEHAVIORAL & LIFESTYLE THERAPY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 145 TURKEY NON-INVASIVE/ ENDOSCOPIC PROCEDURES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 146 TURKEY INTRAGASTRIC BALLOON (IGB) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 147 TURKEY MEDICAL DEVICES & TECHNOLOGIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 148 TURKEY OBESITY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)

TABLE 149 TURKEY OBESITY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 150 TURKEY OBESITY TREATMENT MARKET, BY PATIENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 151 NETHERLANDS OBESITY TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 152 NETHERLANDS PHARMACOLOGICAL TREATMENT (ANTI-OBESITY DRUGS) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 153 NETHERLANDS CENTRALLY ACTING ANORECTICS IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 154 NETHERLANDS BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 155 NETHERLANDS RESTRICTIVE SURGERIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 156 NETHERLANDS COMBINATION SURGERIES IN OBESITY TREATMENT MARKET, BY CLASS, 2018-2032 (USD THOUSAND)

TABLE 157 NETHERLANDS BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY APPROACH, 2018-2032 (USD THOUSAND)

TABLE 158 NETHERLANDS BEHAVIORAL & LIFESTYLE THERAPY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 159 NETHERLANDS NON-INVASIVE/ ENDOSCOPIC PROCEDURES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 160 NETHERLANDS INTRAGASTRIC BALLOON (IGB) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 161 NETHERLANDS MEDICAL DEVICES & TECHNOLOGIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 162 NETHERLANDS OBESITY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)

TABLE 163 NETHERLANDS OBESITY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 164 NETHERLANDS OBESITY TREATMENT MARKET, BY PATIENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 165 SWITZERLAND OBESITY TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 166 SWITZERLAND PHARMACOLOGICAL TREATMENT (ANTI-OBESITY DRUGS) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 167 SWITZERLAND CENTRALLY ACTING ANORECTICS IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 168 SWITZERLAND BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 169 SWITZERLAND RESTRICTIVE SURGERIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 170 SWITZERLAND COMBINATION SURGERIES IN OBESITY TREATMENT MARKET, BY CLASS, 2018-2032 (USD THOUSAND)

TABLE 171 SWITZERLAND BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY APPROACH, 2018-2032 (USD THOUSAND)

TABLE 172 SWITZERLAND BEHAVIORAL & LIFESTYLE THERAPY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 173 SWITZERLAND NON-INVASIVE/ ENDOSCOPIC PROCEDURES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 174 SWITZERLAND INTRAGASTRIC BALLOON (IGB) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 175 SWITZERLAND MEDICAL DEVICES & TECHNOLOGIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 176 SWITZERLAND OBESITY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)

TABLE 177 SWITZERLAND OBESITY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 178 SWITZERLAND OBESITY TREATMENT MARKET, BY PATIENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 179 POLAND OBESITY TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 180 POLAND PHARMACOLOGICAL TREATMENT (ANTI-OBESITY DRUGS) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 181 POLAND CENTRALLY ACTING ANORECTICS IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 182 POLAND BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 183 POLAND RESTRICTIVE SURGERIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 184 POLAND COMBINATION SURGERIES IN OBESITY TREATMENT MARKET, BY CLASS, 2018-2032 (USD THOUSAND)

TABLE 185 POLAND BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY APPROACH, 2018-2032 (USD THOUSAND)

TABLE 186 POLAND BEHAVIORAL & LIFESTYLE THERAPY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 187 POLAND NON-INVASIVE/ ENDOSCOPIC PROCEDURES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 188 POLAND INTRAGASTRIC BALLOON (IGB) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 189 POLAND MEDICAL DEVICES & TECHNOLOGIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 190 POLAND OBESITY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)

TABLE 191 POLAND OBESITY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 192 POLAND OBESITY TREATMENT MARKET, BY PATIENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 193 IRELAND OBESITY TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 194 IRELAND PHARMACOLOGICAL TREATMENT (ANTI-OBESITY DRUGS) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 195 IRELAND CENTRALLY ACTING ANORECTICS IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 196 IRELAND BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 197 IRELAND RESTRICTIVE SURGERIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 198 IRELAND COMBINATION SURGERIES IN OBESITY TREATMENT MARKET, BY CLASS, 2018-2032 (USD THOUSAND)

TABLE 199 IRELAND BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY APPROACH, 2018-2032 (USD THOUSAND)

TABLE 200 IRELAND BEHAVIORAL & LIFESTYLE THERAPY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 201 IRELAND NON-INVASIVE/ ENDOSCOPIC PROCEDURES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 202 IRELAND INTRAGASTRIC BALLOON (IGB) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 203 IRELAND MEDICAL DEVICES & TECHNOLOGIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 204 IRELAND OBESITY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)

TABLE 205 IRELAND OBESITY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 206 IRELAND OBESITY TREATMENT MARKET, BY PATIENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 207 AUSTRIA OBESITY TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 208 AUSTRIA PHARMACOLOGICAL TREATMENT (ANTI-OBESITY DRUGS) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 209 AUSTRIA CENTRALLY ACTING ANORECTICS IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 210 AUSTRIA BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 211 AUSTRIA RESTRICTIVE SURGERIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 212 AUSTRIA COMBINATION SURGERIES IN OBESITY TREATMENT MARKET, BY CLASS, 2018-2032 (USD THOUSAND)

TABLE 213 AUSTRIA BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY APPROACH, 2018-2032 (USD THOUSAND)

TABLE 214 AUSTRIA BEHAVIORAL & LIFESTYLE THERAPY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 215 AUSTRIA NON-INVASIVE/ ENDOSCOPIC PROCEDURES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 216 AUSTRIA INTRAGASTRIC BALLOON (IGB) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 217 AUSTRIA MEDICAL DEVICES & TECHNOLOGIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 218 AUSTRIA OBESITY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)

TABLE 219 AUSTRIA OBESITY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 220 AUSTRIA OBESITY TREATMENT MARKET, BY PATIENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 221 NORWAY OBESITY TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 222 NORWAY PHARMACOLOGICAL TREATMENT (ANTI-OBESITY DRUGS) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 223 NORWAY CENTRALLY ACTING ANORECTICS IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 224 NORWAY BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 225 NORWAY RESTRICTIVE SURGERIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 226 NORWAY COMBINATION SURGERIES IN OBESITY TREATMENT MARKET, BY CLASS, 2018-2032 (USD THOUSAND)

TABLE 227 NORWAY BARIATRIC SURGERY IN OBESITY TREATMENT MARKET, BY APPROACH, 2018-2032 (USD THOUSAND)

TABLE 228 NORWAY BEHAVIORAL & LIFESTYLE THERAPY IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 229 NORWAY NON-INVASIVE/ ENDOSCOPIC PROCEDURES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 230 NORWAY INTRAGASTRIC BALLOON (IGB) IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 231 NORWAY MEDICAL DEVICES & TECHNOLOGIES IN OBESITY TREATMENT MARKET, BY TYPE, 2018-2032 (USD THOUSAND)

TABLE 232 NORWAY OBESITY TREATMENT MARKET, BY AGE GROUP, 2018-2032 (USD THOUSAND)

TABLE 233 NORWAY OBESITY TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)

TABLE 234 NORWAY OBESITY TREATMENT MARKET, BY PATIENT TYPE, 2018-2032 (USD THOUSAND)

TABLE 235 REST OF EUROPE OBESITY TREATMENT MARKET, BY TREATMENT TYPE, 2018-2032 (USD THOUSAND)

图片列表

FIGURE 1 EUROPE OBESITY TREATMENT MARKET: SEGMENTATION

FIGURE 2 EUROPE OBESITY TREATMENT MARKET: DATA TRIANGULATION

FIGURE 3 EUROPE OBESITY TREATMENT MARKET: DROC ANALYSIS

FIGURE 4 EUROPE OBESITY TREATMENT MARKET: REGIONAL MARKET ANALYSIS

FIGURE 5 EUROPE OBESITY TREATMENT MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE OBESITY TREATMENT MARKET: LIFELINE CURVE

FIGURE 7 EUROPE OBESITY TREATMENT MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 EUROPE OBESITY TREATMENT MARKET: DBMR MARKET POSITION GRID

FIGURE 9 EUROPE OBESITY TREATMENT MARKET: MARKET END USER COVERAGE GRID

FIGURE 10 EUROPE OBESITY TREATMENT MARKET: VENDOR SHARE ANALYSIS

FIGURE 11 EUROPE OBESITY TREATMENT MARKET: SEGMENTATION

FIGURE 12 EUROPE OBESITY TREATMENT MARKET EXECUTIVE SUMMARY

FIGURE 13 STRATEGIC DECISIONS

FIGURE 14 FIVE SEGMENTS COMPRISE THE EUROPE OBESITY TREATMENT MARKET , BY TREATMENT TYPE

FIGURE 15 RISING PREVALENCE OF OBESITY IS EXPECTED TO DRIVE THE GROWTH OF EUROPE OBESITY TREATMENT MARKET FROM 2025 TO 2032

FIGURE 16 THE PHARMACOLOGICAL TREATMENTS (ANTI-OBESITY DRUGS) SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE OBESITY TREATMENT MARKET IN 2025 - 2032

FIGURE 17 MARKET OVERVIEW

FIGURE 18 PREVALENCE OF OBESITY IN ADULTS AGE 20 AND OLDER, BY SEX AND AGE: UNITED STATES, AUGUST 2021–AUGUST 2023 SOURCE: CENTERS FOR DISEASE CONTROL AND PREVENTION.

FIGURE 19 SHARE OF PRE-OBESE AND OBESE PERSONS AGED 16 YEARS OR OVER, BY SEX, 2022 (%)

FIGURE 20 EUROPE OBESITY TREATMENT MARKET: BY TREATMENT TYPE, 2024

FIGURE 21 EUROPE OBESITY TREATMENT MARKET: BY TREATMENT TYPE, 2025-2032 (USD THOUSAND)

FIGURE 22 EUROPE OBESITY TREATMENT MARKET: BY TREATMENT TYPE, CAGR (2025-2032)

FIGURE 23 EUROPE OBESITY TREATMENT MARKET: BY TREATMENT TYPE, LIFELINE CURVE

FIGURE 24 EUROPE OBESITY TREATMENT MARKET: BY AGE GROUP, 2024

FIGURE 25 EUROPE OBESITY TREATMENT MARKET: BY AGE GROUP, 2025-2032 (USD THOUSAND)

FIGURE 26 EUROPE OBESITY TREATMENT MARKET: BY AGE GROUP, CAGR (2025-2032)

FIGURE 27 EUROPE OBESITY TREATMENT MARKET: BY AGE GROUP, LIFELINE CURVE

FIGURE 28 EUROPE OBESITY TREATMENT MARKET: BY DISTRIBUTION CHANNEL, 2024

FIGURE 29 EUROPE OBESITY TREATMENT MARKET: BY DISTRIBUTION CHANNEL, 2025-2032 (USD THOUSAND)

FIGURE 30 EUROPE OBESITY TREATMENT MARKET: BY DISTRIBUTION CHANNEL, CAGR (2025-2032)

FIGURE 31 EUROPE OBESITY TREATMENT MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 32 EUROPE OBESITY TREATMENT MARKET: BY PATIENT TYPE, 2024

FIGURE 33 EUROPE OBESITY TREATMENT MARKET: BY PATIENT TYPE, 2025-2032 (USD THOUSAND)

FIGURE 34 EUROPE OBESITY TREATMENT MARKET: BY PATIENT TYPE, CAGR (2025-2032)

FIGURE 35 EUROPE OBESITY TREATMENT MARKET: BY PATIENT TYPE, LIFELINE CURVE

FIGURE 36 EUROPE OBESITY TREATMENT MARKET: SNAPSHOT (2024)

FIGURE 37 EUROPE OBESITY TREATMENT MARKET: COMPANY SHARE 2024 (%)

查看详细信息

研究方法

数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。

DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。

可定制

Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。

Frequently Asked Questions

What is the current market size of the Europe obesity treatment market?

The Europe obesity treatment market size was valued at USD 7.48 million in 2024.

What is the expected growth rate of Europe obesity treatment market?

The Europe obesity treatment market is to grow at a CAGR of 14.0% during the forecast period of 2025 to 2032.

What are the primary segments covered in the Europe obesity treatment market report?

The Europe obesity treatment market is segmented into four notable segments based on treatment type, age group, distribution channel and patient type. On the basis of treatment type, the market is segmented into pharmacological treatments (anti-obesity drugs), bariatric surgery, behavioral & lifestyle therapy, non-invasive/ endoscopic procedures, and medical devices & technologies. On the basis of age group, the market is segmented into adult obesity treatment, geriatric obesity treatment, and pediatric obesity treatment. On the basis of distribution channel, the market is segmented into online pharmacies, retail pharmacies, weight management clinics, hospital pharmacies, and wellness & fitness centers. On the basis of patient type, the market is segmented into class III, class II, and class I.

Who are major players in Europe obesity treatment market?

Companies such as Novo Nordisk A/S (Denmark), Eli Lilly and Company (U.S.), Medtronic (U.S.), Boston Scientific Corporation (U.S.), Johnson & Johnson Services, Inc. (U.S.) are the major companies in the Europe obesity treatment market.

What are the recent product launches by major companies in the Europe obesity treatment market?

In October 2024, VIVUS and UpScriptHealth have launched ChooseQ. online, a telehealth platform that offers convenient access to QSYMIA for weight management. This service allows patients to consult with healthcare providers online and receive QSYMIA directly at home. This initiative aims to improve accessibility to obesity treatment through telemedicine.

Which countries data is covered in the Europe obesity treatment market?

The countries covered in the Europe obesity treatment market are U.S., Canada, Mexico, Germany, U.K., France, Russia, Italy, Spain, Turkey, Poland, Netherlands, Switzerland, Norway, Austria, Ireland, rest of Europe, China, Japan, India, Australia, South Korea, Singapore, Thailand, Philippines, Malaysia, Indonesia, Vietnam, Taiwan, rest of Asia-Pacific, Brazil, Argentina, Chile, Peru, rest of South America, Saudi Arabia, U.A.E., South Africa, Egypt, Kuwait, Israel, and rest of Middle East and Africa.

Which country is expected to dominate in the Europe obesity treatment market?

Germany is expected to dominate the Europe obesity treatment market, particularly in the North America region. This dominance is due to the high prevalence of obesity, advanced healthcare infrastructure, widespread access to innovative weight management solutions, and strong government support for healthcare initiatives.

Which country is expected to witness the highest CAGR in Europe obesity treatment market?

Poland is expected to witness the highest CAGR in the Europe obesity treatment market, driven by rising obesity prevalence, increasing healthcare investments, and growing adoption of advanced weight management solutions.

What are the factors driving the Europe obesity treatment market growth?

The major factors driving the growth of Europe obesity treatment market are increasing prevalence of obesity, innovations in anti-obesity medications, and growth in bariatric and metabolic surgeries.

What are the key trends in the Europe obesity treatment market?

Rising adoption of digital and ai-driven weight management solutions, is emerging as a pivotal trend driving the Europe obesity treatment market.

What are the major challenges in the Europe obesity treatment market?

The primary challenges include long-term follow-ups associated with obesity treatment and addressal of the lifestyle and behavioural changes.

Which is the dominating segment in the Europe obesity treatment market?

The pharmacological treatments (Anti-obesity Drugs) segment is expected to dominate the Europe obesity treatment market, holding a major market share in 2025, due to the growing prevalence of obesity, increased awareness of available weight loss medications, and advancements in drug formulations.

歐洲肥胖治療市場規模、份額和趨勢分析報告—產業概況和2032年預測

通过敏捷供应链咨询解决关税挑战

Europe Obesity Treatment Market

CAGR : 14.00 %

歐洲肥胖治療市場規模

歐洲肥胖治療市場分析

報告範圍和肥胖治療市場細分

歐洲肥胖治療市場關鍵市場洞察

歐洲肥胖治療市場趨勢

歐洲肥胖治療市場動態

歐洲肥胖治療市場範圍

歐洲肥胖治療市場區域分析

歐洲肥胖治療市場份額

歐洲肥胖治療市場的最新發展

Get online access to the report on the World's First Market Intelligence Cloud

目录

表格列表

图片列表

研究方法

可定制

Frequently Asked Questions

报告

市场洞察

支持

解决方案

歐洲肥胖治療市場規模、份額和趨勢分析報告—產業概況和2032年預測

通过敏捷供应链咨询解决关税挑战

Europe Obesity Treatment Market

CAGR : 14.00 %

歐洲肥胖治療市場規模

歐洲肥胖治療市場分析

報告範圍和肥胖治療市場細分

歐洲肥胖治療市場關鍵市場洞察

歐洲肥胖治療市場趨勢

歐洲肥胖治療市場動態

歐洲肥胖治療市場範圍

歐洲肥胖治療市場區域分析

歐洲肥胖治療市場份額

歐洲肥胖治療市場的最新發展

Get online access to the report on the World's First Market Intelligence Cloud

目录

表格列表

图片列表

研究方法

可定制

Frequently Asked Questions

浏览相关页面